The five remaining genes (NRG2, Wnt4, Wnt11, Wnt16 and FGF18) were considered as a "myeloma MGF" although they were not statistically significantly overexpressed in MMC compared to environment cell populations. This evidence concerns the gene WNT4 and plasma cell myeloma.